John T. Treace, Chief Executive Officer at Treace Medical Concepts, bought TMCI on Jun 11, 2026
Data as of Oct 16
▲ BUY$92.5K22,887 shares at $4.04John T. Treace Chief Executive OfficerTMCI Treace Medical Concepts, Inc.
- Traded
- Jun 11, 2026
- Disclosed
- Jun 11, 2026
- Filed
- The same day
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
TMCI since disclosure
−1.0%
Similar stocks (XLV) since disclosure
+14.7%
XLV — its sector index fund
Change in closing price from Jun 11, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.
Other trades in the same filing
- ▲ BUYJohn T. Treace Chief Executive OfficerTMCI Treace Medical Concepts, Inc.$118Kdisclosed Jun 11 · filed 1 day after the trade